The code block below illustrates how one might use # and // as comments in your logic and calculations.

This value you provided is not a number. Please try again.

This value you provided is not an integer. Please try again.

The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.

The value you provided must be within the suggested range

The value you provided is outside the suggested range

This value is admissible, but you may wish to double check it.

The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).

This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.

This field must be a 10 digit U.S. phone number (like 415 555 1212). Please re-enter it now.

This field must be a valid email address (like joe@user.com). Please re-enter it now.

The value you provided could not be validated because it does not follow the expected format. Please try again.

Required format:

/^((0?[1-9])|([1-8][0-9])|(9[0-8]))[0-9]{3}$/

/^((29([-\/])02\3(\d{2}([13579][26]|[2468][048]|04|08)|(1600|2[048]00)))|((((0[1-9]|1\d|2[0-8])([-\/])(0[1-9]|1[012]))|((29|30)([-\/])(0[13-9]|1[012]))|(31([-\/])(0[13578]|1[02])))(\11|\15|\18)\d{4}))$/

/^((02([-\/])29\3(\d{2}([13579][26]|[2468][048]|04|08)|(1600|2[048]00)))|((((0[1-9]|1[012])([-\/])(0[1-9]|1\d|2[0-8]))|((0[13-9]|1[012])([-\/])(29|30))|((0[13578]|1[02])([-\/])31))(\11|\15|\19)\d{4}))$/

/^(((\d{2}([13579][26]|[2468][048]|04|08)|(1600|2[048]00))([-\/])02(\6)29)|(\d{4}([-\/])((0[1-9]|1[012])(\9)(0[1-9]|1\d|2[0-8])|((0[13-9]|1[012])(\9)(29|30))|((0[13578]|1[02])(\9)31))))$/

/^(((\d{2}([13579][26]|[2468][048]|04|08)|(1600|2[048]00))([-\/])02(\6)29)|(\d{4}([-\/])((0[1-9]|1[012])(\9)(0[1-9]|1\d|2[0-8])|((0[13-9]|1[012])(\9)(29|30))|((0[13578]|1[02])(\9)31)))) (\d|[0-1]\d|[2][0-3]):[0-5]\d$/

/^(?!\.)((?!.*\.{2})[a-zA-Z0-9\u0080-\u02AF\u0300-\u07FF\u0900-\u18AF\u1900-\u1A1F\u1B00-\u1B7F\u1D00-\u1FFF\u20D0-\u214F\u2C00-\u2DDF\u2F00-\u2FDF\u2FF0-\u2FFF\u3040-\u319F\u31C0-\uA4CF\uA700-\uA71F\uA800-\uA82F\uA840-\uA87F\uAC00-\uD7AF\uF900-\uFAFF!#$%&'*+\-/=?^_`{|}~\d]+)(\.[a-zA-Z0-9\u0080-\u02AF\u0300-\u07FF\u0900-\u18AF\u1900-\u1A1F\u1B00-\u1B7F\u1D00-\u1FFF\u20D0-\u214F\u2C00-\u2DDF\u2F00-\u2FDF\u2FF0-\u2FFF\u3040-\u319F\u31C0-\uA4CF\uA700-\uA71F\uA800-\uA82F\uA840-\uA87F\uAC00-\uD7AF\uF900-\uFAFF!#$%&'*+\-/=?^_`{|}~\d]+)*@(?!\.)([a-zA-Z0-9\u0080-\u02AF\u0300-\u07FF\u0900-\u18AF\u1900-\u1A1F\u1B00-\u1B7F\u1D00-\u1FFF\u20D0-\u214F\u2C00-\u2DDF\u2F00-\u2FDF\u2FF0-\u2FFF\u3040-\u319F\u31C0-\uA4CF\uA700-\uA71F\uA800-\uA82F\uA840-\uA87F\uAC00-\uD7AF\uF900-\uFAFF\-\.\d]+)((\.([a-zA-Z\u0080-\u02AF\u0300-\u07FF\u0900-\u18AF\u1900-\u1A1F\u1B00-\u1B7F\u1D00-\u1FFF\u20D0-\u214F\u2C00-\u2DDF\u2F00-\u2FDF\u2FF0-\u2FFF\u3040-\u319F\u31C0-\uA4CF\uA700-\uA71F\uA800-\uA82F\uA840-\uA87F\uAC00-\uD7AF\uF900-\uFAFF]){2,63})+)$/i

/^[-+]?\b\d+\b$/

/^[a-z]+$/i

/^\d{10}$/

/^[a-z0-9-_]+$/i

/^[-+]?[0-9]*\.?[0-9]+([eE][-+]?[0-9]+)?$/

/^-?\d+,\d$/

/^-?\d+\.\d$/

/^-?\d+,\d{2}$/

/^-?\d+\.\d{2}$/

/^-?\d+,\d{3}$/

/^-?\d+\.\d{3}$/

/^-?\d+,\d{4}$/

/^-?\d+\.\d{4}$/

/^[-+]?[0-9]*,?[0-9]+([eE][-+]?[0-9]+)?$/

/^($0[2-8]$|0[2-8])\s*\d{4}\s*\d{4}$/

/^(?:$?([2-9]0[1-9]|[2-9]1[02-9]|[2-9][2-9][0-9]|800|811)$?)\s*(?:[.-]\s*)?([0-9]{3})\s*(?:[.-]\s*)?([0-9]{4})(?:\s*(?:#|x\.?|ext\.?|extension)\s*(\d+))?$/

/^((((\+44|0044)\s?\d{4}|$?0\d{4}$?)\s?\d{3}\s?\d{3})|(((\+44|0044)\s?\d{3}|$?0\d{3}$?)\s?\d{3}\s?\d{4})|(((\+44|0044)\s?\d{2}|$?0\d{2}$?)\s?\d{4}\s?\d{4}))(\s?\#(\d{4}|\d{3}))?$/

/^\d{4}$/

/^[ABCEGHJKLMNPRSTVXY]{1}\d{1}[A-Z]{1}\s*\d{1}[A-Z]{1}\d{1}$/i

/^(0[1-9]|[1-9]\d)\d{3}$/

/^(([A-Z]{1,2}\d{1,2})|([A-Z]{1,2}\d[A-Z])) \d[ABD-HJLNP-Z]{2}$/

/^\d{3}-\d\d-\d{4}$/

/^(\d|[0-1]\d|[2][0-3]):([0-5]\d):([0-5]\d)$/

/^(\d|[01]\d|(2[0-3]))(:[0-5]\d){2}$/

/^([0-9]|[0-1][0-9]|[2][0-3]):([0-5][0-9])$/

/^[0-5]\d:[0-5]\d$/

/^[0-9]{4,9}$/

/^\d{5}(-\d{4})?$/

x8UccMxindpTU99v7gtNW75YzsjybTH62nuoxV9WrJi

EFIC Online Survey (English)

Researchers at more than 100 hospitals across the United States and other countries are joining to conduct a research study of bleeding in the brain called FASTEST. This study may affect you or someone you know and we need to find out ahead of time what the residents of the U.S. and local communities think about it. THANK YOU for your help and time in completing this survey.

There are no known risks involved in participating in this survey. Your participation in this survey is completely voluntary. You may refuse to participate and not to answer any questions that you do need feel comfortable answering.

FASTEST is a research study involving patients who have had bleeding in the brain also called intracerebral hemorrhage or ICH. ICH occurs because a weakened blood vessel in the brain breaks and the bleeding accumulates in the brain. Most of this bleeding occurs within a few hours of onset of symptoms. The brain injury from ICH is usually very severe and over 40% of people with ICH are dead within a month and only 20% can independently care for themselves at 6 months. There is currently no treatment for ICH that is scientifically proven to improve outcome.

Because of the severity of the brain injury, patients with ICH are usually very poorly responsive and cannot tell physicians whether or not they would want to participate in a study.

The FASTEST research study is being done to determine if recombinant Factor VIIa (rFVIIa), a protein that our body makes to stop bleeding at a site of injury to a blood vessel, can slow bleeding in the brain and improve outcome. rFVIIa is approved for treatment of bleeding in patients who have inherited lack of clotting factors but is not approved for treatment of ICH. In previous research studies in people that had a stroke caused by ICH, treatment with rFVIIa showed different results. In one study it slowed bleeding in the brain compared to placebo (no active ingredient) and improved outcome at 90 days after the stroke. In another larger study that included more participants, it slowed bleeding but it did not improve outcome.

Participants chosen for the current FASTEST study represent the subgroup of patients with ICH, from the previous studies, who may be most likely to benefit. For example, it appeared that participants treated sooner after their stroke did better and this is why the treatment in the FASTEST study must be given within 2 hours of onset of symptoms. In all of these studies, serious side effects, such as heart attacks or strokes due to blockages of blood vessels, occurred slightly more often in participants that received rFVIIa.

Have you or someone you know ever experienced bleeding the brain or ICH? (check all that apply)

I have

My child has

A family member or loved one has

Someone else I know has

Participants in the FASTEST study are put at random, that is by chance, in one of 2 groups. They have an equal chance of getting rFVIIa or placebo (no active ingredient). One group receives rFVIIa intravenously over 2 minutes within two hours of onset of symptoms and the other group receives placebo. We do not know if rFVIIa is better than placebo for patients with bleeding in the brain. The results of the FASTEST study will help doctors discover if rFVIIa improves outcome in patients with bleeding in the brain. Medical care otherwise will be identical for the two treatment groups including close management of blood pressure and care within an intensive care unit. The study team will follow participants for 180 days after enrollment to evaluate the outcome.

Patients usually must consent to be in a medical study. The patients in this study will be unable to consent for themselves. When possible, consent to participate in the study is sought from the family member or legal representative of a patient with ICH before including the patient in a study. However, since the study medication must be given within 2 hours of onset of symptoms, there might not be enough time to locate and talk to the person's family member or legal representative about the study. If a family member or representative of the patient is not available to decide for the patient, a patient may be enrolled in this study without consent. This is called Exception from Informed Consent (EFIC) for emergency research. Once the family member or legal representative is located, they will be asked to give their permission for the patient with ICH to continue in the study. Because of this, we are asking community members to think about this research and let us know what you think about the study.

The U.S. federal government has created a set of special rules for exception from informed consent for emergency research. EFIC can only be used when:

The person's life is at risk, AND,
The best treatment is not known, AND
The study might help the person, AND

It is not possible to get permission:
from the person because of his or her medical condition nor
from the person's guardian because there is a very short amount of time required to treat the medical problem

Before researchers may do a study using EFIC, they must provide information about the study to the community and get their feedback. That is why we are asking you to complete this survey today.

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

FASTEST is an important study to do

reset

If I had bleeding in the brain, I would be okay with being included in FASTEST without giving my consent ahead of time.

reset

If my spouse or family member had bleeding in the brain, I would be okay with him/her being included in FASTEST without giving my consent ahead of time.

reset

I am in favor of this study being conducted in my community.

reset

Do you think that FASTEST researchers will seriously consider what community members like you have to say about this study before starting it?

Yes

I don't know

reset

Do you feel that you have been given enough information to give your informed opinion about whether you think it is okay for researchers to do the FASTEST study?

Yes

reset

If No, What additional information would you still like to know?
Links for more information are available at the end of the survey.

Expand

We would like to hear your thoughts in your own words.

Do you have any positive thoughts or comments that you wish to share about the FASTEST study being in your community?

Expand

Do you have any negative thoughts or concerns that you wish to share about the FASTEST study being in your community?

Expand

Would you like to tell doctors that you do not want to participate in FASTEST?

Yes

reset

If yes, click on this < <>> that will provide a card that can be printed or copied on a piece of paper that you can carry on your person in a wallet or purse. This card will tell doctors who may evaluate you for a brain hemorrhage that you don't want to be in the FASTEST study.

Attachment:FASTEST_OptOut Cards_7Oct2020_single updated EMAIL no phone.pdf

Lastly, so that we can make sure we are hearing from a wide range of residents from the US and your local community, please complete the following final questions about yourself. This information is only used to demonstrate community participation and is not retained for research.

What is your zip code of residence?

What is your age?

Are you:

Are you Hispanic or Latino?

Yes

reset

Which one or more of the following would you say is your race: (Check all that apply)

White, including Middle Eastern

Black or African American

Asian

Native Hawaiian or Other Pacific Islander

American Indian or Alaska Native

Other [specify]

Other

Expand

What is your primary language

English

Spanish

Arabic

Catonese

Other [specify]

Other

Expand

What is the highest grade or year of school you completed?

How did you hear about this survey?

In an email or online from a group or organization you are a member of

At an event

Facebook ad

Other social media

Other [specify]

reset

If you received this survey in an email or online, please list the name of the group or organization and the social media account, if applicable.

Expand

What was the date of the event that you learned about the FASTEST Study?

M-D-Y

Other

Expand

Please provide below, any additional comments, concerns or questions you would like to share with the FASTEST study team:

Expand

Which FASTEST Study Site are you near? Please mark all that apply

University of Alabama Hospital, Birmingham, AL

St. Joseph's Hospital and Medical Center, Phoenix, AZ

Cedars-Sinai Medical Center, Los Angeles, CA

Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA

Mills-Peninsula Medical Center, Burlingame, CA

Ronald Reagan UCLA Medical Center, Los Angeles, CA

San Francisco General Hospital, San Francisco, CA

UC Irvine Medical Center, Orange, CA

UCSD Health La Jolla, La Jolla, CA

UCSD Medical Center - Hillcrest Hospital, San Diego, CA

UCSF Medical Center, San Francisco, CA

University of Colorado Hospital, Aurora, CO

Grady Memorial Hospital, Atlanta, GA

Wellstar Health Systems, Kennestone Regional Medical Center, Marietta, GA

The Queen's Medical Center, Honolulu, HI

Central DuPage Hospital, Winfield, IL

Northwestern Memorial Hospital, Chicago, IL

University of Chicago Medical Center, Chicago, IL

Massachusetts General Hospital, Boston, MA

UMASS Memorial Medical Center, Worcester, MA

Fairview Southdale Hospital, Edina, MN

Mayo Clinic Saint Mary's Campus, Rochester, MN

Regions Hospital, St. Paul, MN

University of Minnesota Medical Center Hospital, Minneapolis, MN

Barnes Jewish Hospital, St. Louis, MO

St. Josephs Regional Medical Center, Paterson, NJ

Mount Sinai West, New York, NY

North Shore University Hospital, Manhasset, NY

Stony Brook University Hospital, Stony Brook, NY

Wake Forest Baptist Medical Center, Winston-Salem, NC

Mount Carmel East Hospital, Columbus OH

Riverside Methodist Hospital, Columbus, OH

OSU Wexner Medical Center, Columbus, OH

Toledo Hospital (ProMedica), Toledo, OH

University of Cincinnati Medical Center, Cincinnati, OH

Providence St. Vincent Medical Center, Portland, OR

Thomas Jefferson University, Philadelphia, PA

Prisma Health (Greenville Hospital System), Greenville, SC

Medical University of South Carolina University Hospital, Charleston, SC

Memorial Hermann Texas Medical Center, Houston, TX

University of Utah Healthcare, Salt Lake City, UT

VCU Medical Center, Richmond, VA

UF Health Shands Hospital, Gainesville, FL

Sarasota Memorial Hospital / Intercoastal, Sarasota, FL

Mayo Clinic Jacksonville, Jacksonville, FL

Temple University Hospital, Philadelphia, PA

Henry Ford, Detroit, MI

Ascension St. John, Tulsa, OK

University of California - Davis, Sacramento, CA

Jackson Memorial Hospital, Miami, FL

Abbott Northwestern Hospital, Minneapolis, MN

University of Buffalo, Buffalo, NY

A copy of the main study informed consent is available for your review.

Attachment:Master ICF Pro00041014 Apr2921 Watermarked 29July2022.pdf

Thank You!

For more information please, see the FASTEST website, which will open when you submit the survey.

You have selected an option that triggers this survey to end right now.

To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.